i3 Selects 7 African Startups to Receive Up to $225K at 3rd Cohort - Tech
5 Articles
5 Articles
Nigeria’s RxAll and Sproxil selected for i3’s healthtech cohort among 5 others
Two Nigerian healthtech startups, RxAll and Sproxil, are among seven growth-stage companies selected for the third cohort of Investing in Innovation Africa (i3). i3 is a pan-African initiative aimed at scaling innovative healthcare solutions across the continent. Announced today, the cohort focuses on transforming pharmacy services, a critical frontline of healthcare delivery in Africa, where pharmacies account for up to 70% of initial healthcar…
i3 Selects 7 African Startups to Receive Up to $225K at 3rd Cohort - Tech
Key Highlights The pan-African Investing in Innovation (i3) program is funded by the Gates Foundation and sponsored by MSD, Cencora (formerly AmerisourceBergen), Endless Foundation, HELP Logistics (a subsidiary of the Kühne Foundation), Sanofi’s Global Health Unit and Chemonics to invest in the most promising growth-stage companies building the future of pharmacy care in Africa. The 3rd cohort comprises 7 growth-stage startups operating in 19 …
i3 Backs 7 African Healthtechs With USD 225 K In Switch To Growth-Stage Bets
Investing in Innovation Africa (i3), the Gates Foundation-backed initiative accelerating healthtech in Africa, has announced the third cohort of startups to receive up to USD 225 K each in funding and partnership support. This year’s cohort comes with a strategic pivot: a narrowed focus on seven growth-stage companies building pharmacy-focused innovations, a decision triggered by the January 2025 “stop-work” directive on foreign aid from the Tru…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage